Carboplatin’s future in breast cancer treatment

(43)

The NRG-GY022 Study for Patients with #cancer Receiving Carboplatin

(8)

Chemo drug carboplatin shortage

(2:22)

500k Americans Facing Chemo Drug Shortages

(54)

Conclusion: Future Direction of Breast Cancer Treatment

(4:50)

Dr. Sikov on Bevacizumab or Carboplatin Impact On TNBC Subtype

(1:45)

Future Trends for Bladder Cancer Treatment - Bladder Cancer Video Library

(2:43)

Understanding Carboplatin: A Patient's Guide

(4:46)

Is carboplatin an effective addition in the treatment of breast cancer?

(1:34)

CeLEBrATE: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage SCLC

(54)

ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew Sedona

(42:2)

Future Directions for Treating Advanced Ovarian Cancers

(6:11)

Future Role of PARP Inhibition in BRCA+ Breast Cancer

(4:59)

OBGYN Chemo: Carboplatin

(1:36)

ASCO’s Julie Gralow: At least 100,000 cancer patients affected by cisplatin, carboplatin shortage

(22:38)

NABNEC: nab-paclitaxel + carboplatin as 1L treatment of gastrointestinal neuroendocrine carcinomas

(1:5)

Carboplatin Chemotherapy: The Vital Weapon Against Cancer You Need to Know About

(1:13)

First-Line Carboplatin and Pemetrexed With Pembrolizumab for NSCLC

(2:38)

OvarInform: Knowledge Series featuring The Advances And Future Scenarios in PARP Inhibitors

(28:55)

Carboplatin Versus Cisplatin in Cervical Cancer

(2:57)